Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
PET in oncology: Will it replace the other modalities?
1997
Nasopharyngeal carcinoma
2005 Standout
Adjuvant treatment of brain metastases
2001
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
1993
Radiosurgery for non—small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control
2002
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy
2011
Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
1999
Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer
2004
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
1996
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
2003
Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method
2001
PET and [18F]-FDG in oncology: A clinical update
1996
FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
2002
Cushing's syndrome
2015 Standout
The role of PET in monitoring therapy
2005
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Colorectal cancer
2013 Standout
Imaging Changes after Stereotactic Radiosurgery of Primary and Secondary Malignant Brain Tumors
2002
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
1993
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Conformity index: A review
2006 Standout
Surgery versus radiosurgery in the treatment of brain metastasis
1996
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy
2001
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases
1999
Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol 90-05
1996
Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors
2002
Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician’s point of view
2003
Clinical role of positron emission tomography in oncology
2001
Practice parameters for the management of single brain metastasis
2000
Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
1998
Serial MR imaging of intracranial metastases after radiosurgery
1997
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
1999
FDG Accumulation and Tumor Biology
1998
Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain
1997
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control
1997 StandoutNobel
Stereotactic irradiation without whole-brain irradiation for single brain metastasis
1997
Radiology of colorectal cancer
2002
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The fusion of anatomic and physiologic imaging in the management of patients with cancer
2001
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
2000
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Diffusion Changes in a Tumor and Peritumoral Tissue After Stereotactic Irradiation for Brain Tumors
2006 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
Early Effects of Gamma Knife Radiosurgery on Brain Metastases: Assessment by <SUP>201</SUP>TlCl SPECT and <SUP>99m</SUP>Tc-DTPA-Human Serum Albumin SPECT
1997
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.
1993
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.
1998
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
2006
Reproducibility of metabolic measurements in malignant tumors using FDG PET.
1999
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors
2008
Works of J. Romahn being referenced
Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation
1993
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.
1991
Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score.
1992